OPTIMAL MARKET TECHNOLOGIES Trademark
Trademark Overview
On Wednesday, October 22, 2025, a trademark application was filed for OPTIMAL MARKET TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the OPTIMAL MARKET TECHNOLOGIES trademark a serial number of 99456223. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, July 20, 2026. This trademark is owned by RQD* CLEARING, LLC. The OPTIMAL MARKET TECHNOLOGIES trademark is filed in the Insurance & Financial Services category with the following description:
Automated securities brokerage; Financial services, namely, assisting others with the completion of financial transactions for stocks, bonds, securities and equities; Financial services, namely, the trading of financial instruments, securities, shares, options and other derivative products; Providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; Securities brokerage; Securities brokerage services; Securities trade execution services; Trading in securities; Trading of securities options
General Information
| Serial Number | 99456223 |
| Word Mark | OPTIMAL MARKET TECHNOLOGIES |
| Filing Date | Wednesday, October 22, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, July 20, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 11, 2026 |
Trademark Statements
| NOT AVAILABLE | "MARKET TECHNOLOGIES" |
| Goods and Services | Automated securities brokerage; Financial services, namely, assisting others with the completion of financial transactions for stocks, bonds, securities and equities; Financial services, namely, the trading of financial instruments, securities, shares, options and other derivative products; Providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; Securities brokerage; Securities brokerage services; Securities trade execution services; Trading in securities; Trading of securities options |
Classification Information
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 22, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | RQD* CLEARING, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | NEW YORK, NY 10281
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, October 22, 2025 | NEW APPLICATION ENTERED |
| Wednesday, October 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 22, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 9, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, March 11, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 11, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 11, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 11, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 11, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 11, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 6, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, July 6, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, July 6, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 9, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 9, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 9, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 9, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
